- Report
- November 2023
- 312 Pages
Global
From €5277EUR$5,648USD£4,350GBP
- Report
- February 2024
- 250 Pages
Global
From €4834EUR$5,000USD£4,125GBP
- Report
- February 2024
- 400 Pages
Global
From €4834EUR$5,000USD£4,125GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,125GBP
- Report
- February 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,125GBP
- Report
- November 2023
- 180 Pages
Global
From €5753EUR$5,950USD£4,909GBP
- Report
- November 2023
- 141 Pages
Global
From €2416EUR$2,499USD£2,062GBP
- Report
- October 2023
- 139 Pages
Global
From €2416EUR$2,499USD£2,062GBP
- Report
- November 2023
- 190 Pages
Global
From €4738EUR$4,900USD£4,042GBP
- Report
- February 2024
- 179 Pages
Global
From €4593EUR$4,750USD£3,919GBP
- Report
- February 2024
- 190 Pages
Global
From €4738EUR$4,900USD£4,042GBP
- Report
- May 2023
- 57 Pages
North America
From €1450EUR$1,500USD£1,237GBP
- Report
- October 2022
- 330 Pages
Global
From €4640EUR$4,799USD£3,959GBP
- Report
- March 2023
- 165 Pages
Global
From €4640EUR$4,799USD£3,959GBP
- Report
- February 2021
- 256 Pages
Global
From €4640EUR$4,799USD£3,959GBP
- Report
- May 2019
- 480 Pages
Global
From €4351EUR$4,500USD£3,712GBP
- Report
- March 2023
- 185 Pages
Global
From €5318EUR$5,500USD£4,537GBP
- Report
- February 2023
- 123 Pages
Global
From €5318EUR$5,500USD£4,537GBP
- Report
- August 2022
- 382 Pages
Global
From €3384EUR$3,500USD£2,887GBP
- Report
- July 2022
- 317 Pages
Global
From €3384EUR$3,500USD£2,887GBP
The Biological Products for Human Use market is a subset of the biopharmaceutical industry, which focuses on the development and production of drugs and other treatments derived from living organisms. These products are used to treat a variety of medical conditions, ranging from cancer to autoimmune diseases. Biological products are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create new proteins or other molecules.
The Biological Products for Human Use market is highly regulated, with stringent safety and efficacy standards in place to ensure the safety of patients. Companies in this market must adhere to Good Manufacturing Practices (GMP) and other regulatory requirements in order to obtain approval from regulatory authorities.
Some of the major companies in the Biological Products for Human Use market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more